85
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Neuropsychiatric Symptoms Predict Faster Cognitive Decline in Dementia Collaborative Care Than Antipsychotic Use

ORCID Icon, , , & ORCID Icon
Pages 689-696 | Received 14 Dec 2023, Accepted 16 Mar 2024, Published online: 26 Mar 2024

References

  • Bhat A, Biswas A, Das G, Lahiri D, Dubey S, Mukherjee A. Behavioral variations among vascular cognitive impairment subtypes - A comparative study. Appl Neuropsychol Adult. 2021;30(4):1–8.
  • Manso-Calderón R, Cacabelos-Pérez P, Sevillano-García MD, Herrero-Prieto ME, González-Sarmiento R. The impact of vascular burden on behavioural and psychological symptoms in older adults with dementia: the BEVASDE study. Neurol Sci. 2020;41(1):165–174. doi:10.1007/s10072-019-04071-3
  • Tsai WC, Lin HC, Chang CC, et al. Neuropsychiatric symptoms in parkinson’s disease: association with caregiver distress and disease severity. Int Psychogeriatr. 2020;32(6):733–739. doi:10.1017/S1041610219001510
  • Chen YJ, Wang WF, Jhang KM, Chang MC, Chang CC, Liao YC. Prediction of Institutionalization for patients with dementia in Taiwan according to condition at entry to dementia collaborative care. J Appl Gerontol. 2022;41(5):1357–1364. doi:10.1177/07334648211073129
  • Knopman DS, Berg JD, Thomas R, Grundman M, Thal LJ, Sano M. Nursing home placement is related to dementia progression: experience from a clinical trial. alzheimer’s disease cooperative study. Neurology. 1999;52(4):714–718. doi:10.1212/WNL.52.4.714
  • Nation DA, Ho JK, Dutt S, Han SD, Lai MHC. Neuropsychological decline improves prediction of dementia beyond alzheimer’s disease biomarker and mild cognitive impairment diagnoses. J Alzheimers Dis. 2019;69(4):1171–1182. doi:10.3233/JAD-180525
  • Callahan CM, Boustani MA, Unverzagt FW, et al. Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA. 2006;295(18):2148–2157. doi:10.1001/jama.295.18.2148
  • Vickrey BG, Mittman BS, Connor KI, et al. The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial. Ann Intern Med. 2006;145(10):713–726. doi:10.7326/0003-4819-145-10-200611210-00004
  • Törmälehto S, Martikainen J, Bell JS, Hallikainen I, Koivisto AM. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in alzheimer’s disease over a three-year period: kuopio ALSOVA study. Int Psychogeriatr. 2017;29(10):1723–1733. doi:10.1017/S1041610217001090
  • Rouch I, Pongan E, Trombert B, et al. One-year evolution of behavioral and psychological symptoms of dementia in patients initially hospitalized in cognitive behavioral units: the EVITAL prospective cohort. J Alzheimers Dis. 2017;57(1):147–155. doi:10.3233/JAD-161023
  • Pitkänen A, Alanen HM, Kampman O, Leinonen E. Outcome of neuropsychiatric symptoms and daily functioning of patients with dementia treated on an acute psychogeriatric ward. Nord J Psychiatry. 2018;72(7):521–525. doi:10.1080/08039488.2018.1532021
  • Mallo SC, Patten SB, Ismail Z, et al. Does the neuropsychiatric inventory predict progression from mild cognitive impairment to dementia? A systematic review and meta-analysis. Ageing Res Rev. 2020;58:101004. doi:10.1016/j.arr.2019.101004
  • Jiang F, Cheng C, Huang J, Chen Q, Le W. Mild behavioral impairment: an early sign and predictor of alzheimer’s disease dementia. Curr Alzheimer Res. 2022;19(6):407–419. doi:10.2174/1567205019666220805114528
  • Dietlin S, Soto M, Kiyasova V, et al. Neuropsychiatric symptoms and risk of progression to alzheimer’s disease among mild cognitive impairment subjects. J Alzheimers Dis. 2019;70(1):25–34. doi:10.3233/JAD-190025
  • Krell-Roesch J, Syrjanen JA, Machulda MM, et al. Neuropsychiatric symptoms and the outcome of cognitive trajectories in older adults free of dementia: the mayo clinic study of aging. Int J Geriatr Psychiatry. 2021;36(9):1362–1369. doi:10.1002/gps.5528
  • Rosenberg PB, Mielke MM, Han D, et al. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of alzheimer’s disease. Int J Geriatr Psychiatry. 2012;27(12):1248–1257. doi:10.1002/gps.3769
  • Honjo Y, Ide K, Takechi H. Most families tend to realize progress of alzheimer’s disease when behavioural and psychological symptoms are obvious. Psychogeriatrics. 2022;22(3):317–323. doi:10.1111/psyg.12815
  • Chen CT, Chang CC, Chang WN, et al. Neuropsychiatric symptoms in alzheimer’s disease: associations with caregiver burden and treatment outcomes. Qjm. 2017;110(9):565–570. doi:10.1093/qjmed/hcx077
  • Chen YJ, Jhang KM, Wang WF, Lin GC, Yen SW, Wu HH. Applying apriori algorithm to explore long-term care services usage status-variables based on the combination of patients with dementia and their caregivers. Front Psychol. 2022;13:1022860. doi:10.3389/fpsyg.2022.1022860
  • Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997;9(Suppl 1):173–6; discussion 7–8. doi:10.1017/S1041610297004870
  • Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–2314. doi:10.1212/WNL.44.12.2308
  • Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233–239. doi:10.1176/jnp.12.2.233
  • Jhang KM, Chang MC, Lo TY, Lin CW, Wang WF, Wu HH. Using The Apriori Algorithm To Classify The Care Needs Of Patients With Different Types Of Dementia. Patient Prefer Adherence. 2019;13:1899–1912. doi:10.2147/PPA.S223816
  • Jhang KM, Wang WF, Chang HF, Liu YH, Chang MC, Wu HH. Care needs of community-residing male patients with vascular cognitive impairment. Neuropsychiatr Dis Treat. 2020;16:2613–2621. doi:10.2147/NDT.S277303
  • Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6(1):45–58; discussion 62. doi:10.1017/S1041610294001602
  • Defrancesco M, Marksteiner J, Kemmler G, et al. Specific neuropsychiatric symptoms are associated with faster progression in alzheimer’s disease: results of the prospective dementia registry (PRODEM-Austria). J Alzheimers Dis. 2020;73(1):125–133. doi:10.3233/JAD-190662
  • Edwin TH, Strand BH, Persson K, Engedal K, Selbæk G, Knapskog AB. Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis. Int Psychogeriatr. 2021;33(8):779–789. doi:10.1017/S1041610220003270
  • Eldholm RS, Barca ML, Persson K, et al. Progression of alzheimer’s disease: a longitudinal study in Norwegian memory clinics. J Alzheimers Dis. 2018;61(3):1221–1232. doi:10.3233/JAD-170436
  • Haaksma ML, Rizzuto D, Leoutsakos JS, et al. Predicting cognitive and functional trajectories in people with late-onset dementia: 2 population-based studies. J Am Med Dir Assoc. 2019;20(11):1444–1450. doi:10.1016/j.jamda.2019.03.025
  • Sung PS, Lee KP, Lin PY, et al. Factors associated with cognitive outcomes after first-ever ischemic stroke: the impact of small vessel disease burden and neurodegeneration. J Alzheimers Dis. 2021;83(2):569–579. doi:10.3233/JAD-210587
  • Kueper JK, Speechley M, Lingum NR, Montero-Odasso M. Motor function and incident dementia: a systematic review and meta-analysis. Age Ageing. 2017;46(5):729–738. doi:10.1093/ageing/afx084
  • Yang YH, Wu MN, Chou PS, Su HC, Lin SH, Sung PS. Longitudinal neuropsychological outcome in Taiwanese alzheimer’s disease patients treated with medication. Curr Alzheimer Res. 2018;15(5):474–481. doi:10.2174/1567205014666171010112518
  • Tampi RR, Bhattacharya G, Marpuri P. Managing Behavioral and Psychological Symptoms of Dementia (BPSD) in the era of boxed warnings. Curr Psychiatry Rep. 2022;24(9):431–440. doi:10.1007/s11920-022-01347-y
  • Oh ES, Rosenberg PB, Rattinger GB, Stuart EA, Lyketsos CG, Leoutsakos JS. Psychotropic medication and cognitive, functional, and neuropsychiatric outcomes in Alzheimer’s Disease (AD). J Am Geriatr Soc. 2021;69(4):955–963. doi:10.1111/jgs.16970
  • Poulin SP, Bergeron D, Dickerson BC. Risk factors, neuroanatomical correlates, and outcome of neuropsychiatric symptoms in alzheimer’s disease. J Alzheimers Dis. 2017;60(2):483–493. doi:10.3233/JAD-160767
  • Kazui H, Yoshiyama K, Kanemoto H, et al. Differences of behavioral and psychological symptoms of dementia in disease severity in four major dementias. PLoS One. 2016;11(8):e0161092. doi:10.1371/journal.pone.0161092
  • Lü W, Duan J, Zhang W, Yang W, Yu W. Relationship between neuropsychiatric symptoms and cognitive functions in patients with cognitive impairment. Psychogeriatrics. 2021;21(5):773–782. doi:10.1111/psyg.12738
  • Cheng ST, Li KK, Or PPL, Losada A. Do caregiver interventions improve outcomes in relatives with dementia and mild cognitive impairment? A comprehensive systematic review and meta-analysis. Psychol Aging. 2022;37(8):929–953. doi:10.1037/pag0000696